CLASS I Drug recall · Reported 30 Mar 2022 · FDA Enforcement Report

Revitaderm Wound Care Gel, (Benzalkonium Chloride recalled

Blaine Labs is recalling Revitaderm Wound Care Gel, (Benzalkonium Chloride in a gel containing transforming growth, distributed nationwide in the US. The recall was initiated on 25 Jan 2022 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot/Batch #: BL 2844, Expiration date 2/19/2023
NDC63347-120
Quantity recalled1119 (1 oz.) bottles/ 772 (3 oz.) tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0668-2022
FDA event ID
89481
Recalling firm
Blaine Labs, Santa Fe Springs, CA
Manufacturer
Blaine Labs Inc.
Classification
Class I
Status
Terminated
Recall initiated
25 Jan 2022
FDA classified
18 Mar 2022
Reported
30 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Timeline

25 Jan 2022Recall initiated by company
18 Mar 2022Classified by FDA+52 days
30 Mar 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.

Product as listed by the FDA

REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC 63347-120-01), Blaine Labs Inc., Santa Fe Springs, CA 90670

Where it was distributed

Nationwide in 17 States to 45 doctors.

Nationwide

Questions about this recall

Why was it recalled?

Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.

Which lots are affected?

Lot/Batch #: BL 2844, Expiration date 2/19/2023

Where was it sold?

Nationwide in 17 States to 45 doctors.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Blaine Labs

All 9

Other Benzalkonium Chloride recalls

All 21